Joseph A Politch1, Kenneth H Mayer, Deborah J Anderson. 1. Division of Reproductive Biology, Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA. joseph.politch@bmc.org
Abstract
BACKGROUND: Information concerning the effects of HIV-1 infection, disease progression, and antiretroviral therapy (ART) on male genital white blood cell (WBC) profiles could provide important insight into genital immune defense in HIV-infected men and seminal HIV transmission mechanisms. OBJECTIVE: To compare concentrations of WBC populations in semen from HIV-1-seronegative (HIV) and HIV-1-seropositive (HIV) men and determine whether HIV disease stage and ART are associated with alterations in seminal WBC profiles. SUBJECTS AND METHODS: Subjects were 102 HIV men, 98 ART-naive (ART) HIV men, and 22 HIV men on dual nucleoside ART, before and 6 months after addition of indinavir. Seminal WBCs, macrophages (MØ), and T-lymphocyte subpopulations were enumerated by immunohistology technique. RESULTS: Seminal CD4 and CD8 T-cell populations were severely depleted in most ART HIV men regardless of peripheral blood CD4 cell count. Seminal MØ counts were reduced by 50%. HIV men on dual nucleoside ART had significantly higher seminal MØ, CD4, and CD8 T-cell counts than ART HIV men; addition of indinavir led to a dramatic (>25-fold, P < 0.001) increase in seminal CD4 T-cell counts which paralleled an increase in blood CD4 cell counts. Two outlier ART HIV men with notably elevated seminal WBC profiles (>20 x 10 WBCs/mL) and infectious cell-associated HIV in semen are described. CONCLUSIONS: HIV infection severely depletes CD4 T cells in the male genital tract as it does at other mucosal sites. This provides evidence that ART HIV men have depressed T cell-dependent genital immune defense functions and are vulnerable to other genital infections that could promote HIV transmission. Seminal CD4 T-cell counts rebounded after treatment with a viral-suppressing ART regimen, indicating that ART may reverse HIV-associated genital immunosuppression. The relative abundance of seminal MØ in HIV men suggests that these cells may be predominant HIV host cells in the male genital tract and vectors of HIV transmission. A subgroup of HIV men with exceptionally elevated seminal MØ and CD4 T-cell counts and HIV titers may be highly infectious and contribute disproportionately to HIV transmission.
BACKGROUND: Information concerning the effects of HIV-1 infection, disease progression, and antiretroviral therapy (ART) on male genital white blood cell (WBC) profiles could provide important insight into genital immune defense in HIV-infectedmen and seminal HIV transmission mechanisms. OBJECTIVE: To compare concentrations of WBC populations in semen from HIV-1-seronegative (HIV) and HIV-1-seropositive (HIV) men and determine whether HIV disease stage and ART are associated with alterations in seminal WBC profiles. SUBJECTS AND METHODS: Subjects were 102 HIVmen, 98 ART-naive (ART) HIVmen, and 22 HIVmen on dual nucleoside ART, before and 6 months after addition of indinavir. Seminal WBCs, macrophages (MØ), and T-lymphocyte subpopulations were enumerated by immunohistology technique. RESULTS: Seminal CD4 and CD8 T-cell populations were severely depleted in most ARTHIVmen regardless of peripheral blood CD4 cell count. Seminal MØ counts were reduced by 50%. HIVmen on dual nucleoside ART had significantly higher seminal MØ, CD4, and CD8 T-cell counts than ARTHIVmen; addition of indinavir led to a dramatic (>25-fold, P < 0.001) increase in seminal CD4 T-cell counts which paralleled an increase in blood CD4 cell counts. Two outlier ARTHIVmen with notably elevated seminal WBC profiles (>20 x 10 WBCs/mL) and infectious cell-associated HIV in semen are described. CONCLUSIONS:HIV infection severely depletes CD4 T cells in the male genital tract as it does at other mucosal sites. This provides evidence that ARTHIVmen have depressed T cell-dependent genital immune defense functions and are vulnerable to other genital infections that could promote HIV transmission. Seminal CD4 T-cell counts rebounded after treatment with a viral-suppressing ART regimen, indicating that ART may reverse HIV-associated genital immunosuppression. The relative abundance of seminal MØ in HIVmen suggests that these cells may be predominant HIV host cells in the male genital tract and vectors of HIV transmission. A subgroup of HIVmen with exceptionally elevated seminal MØ and CD4 T-cell counts and HIV titers may be highly infectious and contribute disproportionately to HIV transmission.
Authors: Kristen V Khanna; Kevin J Whaley; Larry Zeitlin; Thomas R Moench; Karim Mehrazar; Richard A Cone; Zhaohao Liao; James E K Hildreth; Timothy E Hoen; Leonard Shultz; Richard B Markham Journal: J Clin Invest Date: 2002-01 Impact factor: 14.808
Authors: S Tariq Sadiq; Stephen Taylor; Steve Kaye; Julie Bennett; Ruth Johnstone; Patrick Byrne; Andrew J Copas; Susan M Drake; Deenan Pillay; Ian Weller Journal: AIDS Date: 2002-01-25 Impact factor: 4.177
Authors: Patrick Barnable; Giulia Calenda; Thierry Bonnaire; Radhika Menon; Keith Levendosky; Agegnehu Gettie; James Blanchard; Michael L Cooney; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova Journal: Antimicrob Agents Chemother Date: 2015-04-13 Impact factor: 5.191
Authors: Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer Journal: AIDS Date: 2010-01-16 Impact factor: 4.177
Authors: Joseph A Fraietta; Yvonne M Mueller; Duc H Do; Veronica M Holmes; Mary K Howett; Mark G Lewis; Alina C Boesteanu; Sefik S Alkan; Peter D Katsikis Journal: Antimicrob Agents Chemother Date: 2010-07-12 Impact factor: 5.191
Authors: Kerri J Penrose; Barbra A Richardson; Guillaume Besson; Charlene S Dezzutti; Betsy C Herold; Salim S Abdool Karim; John W Mellors; Urvi M Parikh Journal: Sex Transm Dis Date: 2014-11 Impact factor: 2.830
Authors: Maria M Bednar; Blake M Hauser; Li-Hua Ping; Elena Dukhovlinova; Shuntai Zhou; Kathryn T Arrildt; Irving F Hoffman; Joseph J Eron; Myron S Cohen; Ronald Swanstrom Journal: J Virol Date: 2015-07-29 Impact factor: 5.103
Authors: Dror Kolodkin-Gal; Sandrine L Hulot; Birgit Korioth-Schmitz; Randi B Gombos; Yi Zheng; Joshua Owuor; Michelle A Lifton; Christian Ayeni; Robert M Najarian; Wendy W Yeh; Mohammed Asmal; Gideon Zamir; Norman L Letvin Journal: J Virol Date: 2013-10-09 Impact factor: 5.103
Authors: Philip V Nguyen; Jessica K Kafka; Victor H Ferreira; Kristy Roth; Charu Kaushic Journal: Cell Mol Immunol Date: 2014-06-30 Impact factor: 11.530